High Drinking in the Dark (HDID) mice are sensitive to the effects of some clinically relevant drugs to reduce binge-like drinking

[1]  S. Hauser,et al.  Rat animal models for screening medications to treat alcohol use disorders , 2017, Neuropharmacology.

[2]  R. Weinshilboum,et al.  Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice. , 2016, Alcoholism, clinical and experimental research.

[3]  S. Boehm,et al.  Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  K. Mann,et al.  Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human Alcoholics , 2016, Neuropsychopharmacology.

[5]  F. Carvajal,et al.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice. , 2015, Alcoholism, clinical and experimental research.

[6]  C. Whittington,et al.  The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. , 2015, Addiction.

[7]  P. Crowley.  Long-term drug treatment of patients with alcohol dependence. , 2015, Australian prescriber.

[8]  S. Boehm,et al.  Bidirectional enantioselective effects of the GABAB receptor agonist baclofen in two mouse models of excessive ethanol consumption. , 2015, Alcohol.

[9]  J. Crabbe,et al.  Rewarding and aversive effects of ethanol in High Drinking in the Dark selectively bred mice , 2015, Addiction biology.

[10]  P. Borro,et al.  Treatment of alcohol dependence: recent progress and reduction of consumption. , 2014, Minerva medica.

[11]  A. Heinz,et al.  Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging. , 2014, Alcoholism, clinical and experimental research.

[12]  S. Boehm,et al.  Intra-nucleus accumbens shell injections of R(+)- and S(−)-baclofen bidirectionally alter binge-like ethanol, but not saccharin, intake in C57Bl/6J mice , 2014, Behavioural Brain Research.

[13]  G. Bobashev,et al.  Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. , 2014, Addiction.

[14]  J. Crabbe,et al.  “Drinking in the Dark” (DID): A Simple Mouse Model of Binge‐Like Alcohol Intake , 2014, Current protocols in neuroscience.

[15]  G. Colombo,et al.  GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence , 2014, Front. Neurosci..

[16]  J. Crabbe,et al.  High drinking in the dark mice: a genetic model of drinking to intoxication. , 2014, Alcohol.

[17]  R. Spanagel,et al.  Acamprosate Produces Its Anti-Relapse Effects Via Calcium , 2014, Neuropsychopharmacology.

[18]  J. Crabbe,et al.  Progress in a replicated selection for elevated blood ethanol concentrations in HDID mice , 2014, Genes, brain, and behavior.

[19]  J. Crabbe.  The Genetic Complexity of Alcohol Drinking in Rodents , 2014 .

[20]  J. Crabbe,et al.  Selection for drinking in the dark alters brain gene coexpression networks. , 2013, Alcoholism, clinical and experimental research.

[21]  A. Tomie,et al.  Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J mice , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  John P. Didion,et al.  Deconstructing Mus gemischus: advances in understanding ancestry, structure, and variation in the genome of the laboratory mouse , 2013, Mammalian Genome.

[23]  M. Olive,et al.  Safety and Efficacy of Acamprosate for the Treatment of Alcohol Dependence , 2013, Substance abuse : research and treatment.

[24]  L. Lumeng,et al.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: Neurobiological and pharmacological validity , 2012, Pharmacology Biochemistry and Behavior.

[25]  J. Crabbe,et al.  Ethanol Withdrawal-Associated Drinking and Drinking in the Dark: Common and Discrete Genetic Contributions , 2012, Addiction genetics.

[26]  P. Kalivas,et al.  Glutamatergic medications for the treatment of drug and behavioral addictions , 2012, Pharmacology Biochemistry and Behavior.

[27]  D. Goldman,et al.  Pharmacogenetic approaches to the treatment of alcohol addiction , 2011, Nature Reviews Neuroscience.

[28]  R. Prosser,et al.  Circadian and Acamprosate Modulation of Elevated Ethanol Drinking in mPer2 Clock Gene Mutant Mice , 2011, Chronobiology international.

[29]  J. Crabbe,et al.  Alcohol preference drinking in a mouse line selectively bred for high drinking in the dark. , 2011, Alcohol.

[30]  R. Prosser,et al.  Acamprosate-responsive brain sites for suppression of ethanol intake and preference. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  N. Grahame,et al.  Derivation and Characterization of Replicate High- and Low-Alcohol Preferring Lines of Mice and a High-Drinking Crossed HAP Line , 2011, Behavior genetics.

[32]  M. Ford,et al.  Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. , 2011, Alcohol.

[33]  G. Koob,et al.  Preclinical studies of alcohol binge drinking , 2011, Annals of the New York Academy of Sciences.

[34]  D. Hommer,et al.  Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the blues , 2010, Neuroscience & Biobehavioral Reviews.

[35]  K. Mann,et al.  Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy. , 2010, Current pharmaceutical design.

[36]  J. Crabbe,et al.  A Line of Mice Selected for High Blood Ethanol Concentrations Shows Drinking in the Dark to Intoxication , 2009, Biological Psychiatry.

[37]  D. Linsenbardt,et al.  GABAergic modulation of binge-like ethanol intake in C57BL/6J mice , 2007, Pharmacology Biochemistry and Behavior.

[38]  J. Crabbe,et al.  Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41). , 2007, Alcoholism, clinical and experimental research.

[39]  J. Rhodes,et al.  Acute effects of Naltrexone and GBR 12909 on ethanol drinking-in-the-dark in C57BL/6J mice , 2007, Psychopharmacology.

[40]  J. Crabbe,et al.  Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades , 2006, Proceedings of the National Academy of Sciences.

[41]  M. Egli.  Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? , 2005, Addiction biology.

[42]  A. Sharpe,et al.  Ataxia and c-Fos expression in mice drinking ethanol in a limited access session. , 2005, Alcoholism, clinical and experimental research.

[43]  J. Crabbe,et al.  A procedure to produce high alcohol intake in mice , 2005, Psychopharmacology.

[44]  J. Crabbe,et al.  Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice , 2005, Physiology & Behavior.

[45]  J. Crabbe,et al.  Genetic Analysis of Rapid Tolerance to Ethanol's Incoordinating Effects in Mice: Inbred Strains and Artificial Selection , 2004, Behavior genetics.

[46]  J. Park,et al.  Effect of the combination of naltrexone and acamprosate on alcohol intake in mice , 2004, Psychiatry and clinical neurosciences.

[47]  W. Zieglgänsberger,et al.  Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence. , 2003, The American journal on addictions.

[48]  C. Hodge,et al.  Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. , 2002, European journal of pharmacology.

[49]  L. Toth,et al.  Food and water restriction protocols: physiological and behavioral considerations. , 2000, Contemporary topics in laboratory animal science.

[50]  R. Spanagel,et al.  Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. , 1996, European journal of pharmacology.

[51]  J. Crabbe,et al.  Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. , 1990, Alcoholism, clinical and experimental research.

[52]  H. Grüneberg,et al.  Introduction to quantitative genetics , 1960 .

[53]  J. Crabbe.  Use of animal models of alcohol-related behavior. , 2014, Handbook of clinical neurology.

[54]  Gunter Schumann,et al.  The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption , 2005, Nature Medicine.